CAXTON ASSOCIATES LP - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 274 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.

Quarter-by-quarter ownership
CAXTON ASSOCIATES LP ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$497,807
+15.8%
13,035
+33.3%
0.08%
+78.6%
Q2 2022$430,000
-3.8%
9,782
-6.6%
0.04%
+35.5%
Q4 2020$447,000
-66.1%
10,471
-78.7%
0.03%
-73.0%
Q2 2020$1,319,000
+129.8%
49,216
+52.1%
0.12%
+45.6%
Q4 2019$574,00032,3480.08%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders